Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.57 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7198703 | 1.00 | ABCG2 (0.57) | ABCG2CYP1A1CYP1B1CYP19A1CYP1A2 | |
| SCHEMBL8494360 | 0.84 | NFE2L2 (0.63) | CYP1A1CYP1B1CYP19A1CYP1A2MAPT | |
| SCHEMBL2119793 | 0.84 | NFE2L2 (0.63) | CYP1A1CYP1B1CYP19A1CYP1A2MAPT | |
| SCHEMBL5451938 | 0.81 | XDH (0.44) | ABCG2CYP1A1CYP1B1CYP1A2MAPT | |
| SCHEMBL8502492 | 0.81 | CYP1A1 (0.56) | ABCG2CYP1A1CYP1B1CYP19A1CYP1A2 | |
| SCHEMBL8502491 | 0.81 | CYP1A1 (0.56) | ABCG2CYP1A1CYP1B1CYP19A1CYP1A2 | |
| SCHEMBL31474876 | 0.80 | ALDH1A1 (0.56) | ABCG2CYP1A1CYP1B1CYP19A1CYP1A2 | |
| SCHEMBL269268 | 0.80 | ALDH1A1 (0.56) | ABCG2CYP1A1CYP1B1CYP19A1CYP1A2 | |
| SCHEMBL28285216 | 0.80 | XDH (0.50) | ABCG2CYP1A1CYP1B1CYP1A2MAPT | |
| Formaldehyde SCHEMBL5462063 | 0.79 | XDH (0.41) | ABCG2CYP1A1CYP1B1CYP1A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2429292-A1 | COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND METHODS FOR THE TREATMENT OF CANCER | Georgia State University Research Foundation, Inc. (US) | 2012-03-21 | — | — | EP | claimed |
| WO-2010129858-A1 | COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND METHODS FOR THE TREATMENT OF CANCER | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-11-11 | — | — | WO | claimed |
| EP-3959189-B1 | METHOD OF DEPOLYMERISING PHENOLIC POLYMERS | UNIV STELLENBOSCH (ZA) | 2026-01-28 | — | — | EP | disclosed |
| US-12275697-B2 | Method of depolymerising phenolic polymers | STELLENBOSCH UNIVERSITY (ZA) | 2025-04-15 | — | — | US | disclosed |
| US-20220227694-A1 | Method of Depolymerising Phenolic Polymers | STELLENBOSCH UNIVERSITY (ZA) | 2022-07-21 | — | — | US | disclosed |
| EP-3959189-A1 | METHOD OF DEPOLYMERISING PHENOLIC POLYMERS | Stellenbosch University (ZA) | 2022-03-02 | — | — | EP | disclosed |
| WO-2020217209-A1 | METHOD OF DEPOLYMERISING PHENOLIC POLYMERS | STELLENBOSCH UNIVERSITY (ZA) | 2020-10-29 | — | — | WO | disclosed |
| WO-2008156654-A2 | CYTOSKELETON MODULATORS FOR TREATING METABOLIC DISORDERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-12-24 | — | — | WO | disclosed |
| US-6566557-B2 | Oxidation of a phenylpropane compound | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-05-20 | — | — | US | disclosed |
| US-20020133045-A1 | Process for the preparation of substituted trans-cinnamaldehyde, a natural yellow dye, from phenylpropane derivatives | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-09-19 | — | — | US | disclosed |
| WO-2002072709-A1 | A PROCESS FOR THE PREPARATION OF SUBSTITUTED TRANS-CINNAMALDEHYDE, A NATURAL YELLOW DYE, FROM PHENYLPROPANE DERIVATIVES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220227694-A1 | Method of Depolymerising Phenolic Polymers | DCXR, GRHPR, HPD | ABCG2 2718/4885CYP1A1 1803/4885CYP1B1 2444/4885 |
| US-12275697-B2 | Method of depolymerising phenolic polymers | DCXR, GRHPR, HPD | ABCG2 2718/4885CYP1A1 1803/4885CYP1B1 2444/4885 |
| US-20020133045-A1 | Process for the preparation of substituted trans-cinnamaldehyde, a natural yellow dye, from phenylpropane derivatives | CBR3, DDT, DHODH | ABCG2 962/4885CYP1A1 881/4885CYP1B1 1708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.